bleeding was not controlled despite the use of Misoprostol, Syntocinon infusion, Ergometrine, four doses of carboprost, tranexamic acid, 4 units of fresh frozen plasma and recombinant Factor VII. In view of the life-threatening situation, the benefits of the autologous transfusion was considered to outweigh the potential risk of infection and the small risk of amniotic fluid embolism, and a joint decision was made by 2 obstetricians to re-infuse the vaginally salvaged blood. Prior to the manual removal of the placenta, the perineum and vagina had been cleaned with aseptic precautions and covered with sterile drapes. The vaginal blood was retrieved directly via a wide bore suction cannula. Large blood clots retrieved vaginally were collected in a sterile dish under aseptic precautions, from which it was recycled and processed by the cell salvage machine (Haemonetics). She was transfused 380 ml of recycled blood processed with leucocyte-depletion filter. Intraoperatively, she had received further doses of cefuroxime and metronidazole. Haemostasis was achieved after four doses of carboprost tromethamine, two units of cryoprecipitate and two doses of factor VII. The haemoglobin was 7.4 g/dl, platelets and coagulation were normal. Postoperatively, she was monitored on the high dependency unit for 48 h. Intravenous cefuroxime and metronidazole was continued for 48 h followed by oral therapy for seven days. One hour after the bleeding was controlled, she had a temperature of 38.2 C which settled after intravenous paracetamol. She had no further febrile episodes and blood cultures at 48 h was negative. She had no objective signs of postnatal sepsis and recovered well thereafter. She was debriefed about steps undertaken for autologous blood transfusion and the risk of alloimmunization, which was small and not definitely quantifiable. This rare case provides an observation that it is possible to safely retrieve blood lost per vaginum, recycle and re-infuse the blood, without the patient developing complications.This is especially relevant in the context of lessons learnt from previous confidential enquiries addressing steps undertaken in major haemorrhage [4,5]. Therefore, future research should focus on the safety, feasibility and wider application of this therapeutic intervention in cases of major postpartum haemorrhage, especially in those patients who decline allogeneic blood.